The Oxford AHSN region is a leading national and international life sciences cluster, home to a rich and diverse community of innovators, entrepreneurs and researchers. The Oxford AHSN Strategic and Industry Partnerships programme builds evidence for innovations in the real world, working with companies and other partners to accelerate health and economic gains.
In diagnostics, digital health, medtech and pharma, the Oxford AHSN provides expert support along the entire innovation pathway, from idea origination, through concept development, testing and regulatory approval and on to adoption – working closely with the Oxford AHSN Clinical Innovation Adoption programme. It fosters long-term partnerships with industry and a culture of innovation in the NHS, securing more than £100m investment into the Thames Valley region. This work is aligned with the Accelerated Access Collaborative and the requirements of the Office for Life Sciences which is funding AHSNs to establish a network of innovation exchanges.
The Innovation Exchange is an AHSN coordinated approach to identify, select and support the adoption of innovations that improve our economy and patients’ lives. The Innovation Exchange has four structured elements:
- needs definition
- innovator support and signposting
- real world validation
- spread and adoption of supported innovations.
Read more about Strategic and Industry Partnerships and other successful Oxford AHSN programmes in ‘The first five years‘ report published in October 2018.